Integrated Biopharma CFO Dina Masi's 2021 pay rises 6% to $268K
Integrated Biopharma reports 2021 executive compensation
By ExecPay News
Published: October 27, 2021
Integrated Biopharma reported fiscal year 2021 executive compensation information on October 27, 2021.
In 2021, four executives at Integrated Biopharma received on average a compensation package of $254K, a 8% increase compared to previous year.
Average pay of disclosed executives at Integrated Biopharma
Dina Masi, Chief Financial Officer, received $268K in total, which increased by 6% compared to 2020. 90% of Masi's compensation, or $243K, was in salary. Masi also received $17K in option awards and $9.2K in other compensation.
E.Gerald Kay, Chairman, received a compensation package of $257K, which increased by 9% compared to previous year. 80% of the compensation package, or $206K, was in salary.
Christina Kay, Chief Executive Officer, earned $246K in 2021, a 7% increase compared to previous year.
Riva Sheppard, Chief Executive Officer, received $245K in 2021, which increases by 8% compared to 2020.
Integrated Biopharma's fiscal year ends on June 30.
Related executives
You may also like
Source: SEC filing on October 27, 2021.